NEWS & MEETINGS
Insight
Through its professional digital service capabilities, Hippocrates has helped many life sciences companies achieve remarkable success in meeting regulatory requirements, ensuring compliance and improving operational efficiency. We will release the latest training courses and exhibition information as soon as possible. Please visit the official homepage of "Hippocrates" on media such as "WeChat Official Account, Weibo, Zhihu, Bopu, Douyin, Baijiahao, Sohu" to obtain our latest information and live courses.
2025-05-09 15:42:11

Project Launch: Hippocrates Joins Hands with Fangsheng

Read more
2025-10-09 11:10:21

Project Launch

Jiangsu Lihua Biotechnology Co., Ltd. ("Lihua Biotechnology"), a leading domestic Contract Research Organization (CRO), has entered into a strategic cooperation with Shanghai Hippocrates
Read more
2025-10-09 10:29:52

Project Launch

Nantong Novast Pharmaceutical Co., Ltd. (Novast, hereinafter referred to as "Novast Pharmaceutical") has entered into in-depth cooperation with Hippocrates to jointly launch the TMS digital project.
Read more
2025-10-09 13:42:00

Project Launch

The launch of this DMS (Document Management System) digitalization project marks another major upgrade of Fangsheng Pharmaceutical in the field of quality management.
Read more
2025-03-24 09:40:03

Hippocrates has released a new generation of DMS

Recently, Hippocrates, a leading digital solution provider in the life sciences and healthcare sector, announced the launch of its next-generation Document Management System (DMS).
Read more

Project Launch

Recently, Zhejiang Beihede Pharmaceutical Co., Ltd. ("Beihede Pharmaceutical") has reached a strategic cooperation agreement with Shanghai Hippocrates Health Technology Co., Ltd.
Read more

2025 Annual Best Pharmaceutical GMP Document Management System

Concurrently, the annual CMIS Awards Ceremony took place at the summit, aiming to identify and recognize enterprises, elite teams, and outstanding individuals that have demonstrated exceptional wisdom
Read more

Project Launch

Referred to as Convalife Pharmaceuticals, Fukang (Shanghai) Health Technology Co., Ltd. is committed to pharmaceutical R&D and production.
Read more

Annual Pharmaceutical Digital Solution Innovation Award

Hippocrates was awarded the Annual Pharmaceutical Digital Solution Innovation Award
Read more

Work Hand in Hand, Mutual Benefit and Win-Win

Work Hand in Hand, Mutual Benefit and Win-Win | Hippocrates and Dishi Consulting Have Reached a Strategic Cooperation
Read more

Annual Best Entrusted Mfg Quality Mgmt System(eMAH) Award

The 4th Pharmaceutical and Medical Device Digital Conference successfully concluded, and Xingdi won the Annual Best Entrusted Manufacturing Quality Management System (eMAH) Award.
Read more

Breaking News!

Breaking News! 5 Cases of Hipppocrates Selected into the National Innovative Cases of Digital Transformation in the Pharmaceutical Industry
Read more

2024 Best Pharmaceutical GMP Training Management System Award

2024 Best Pharmaceutical GMP Training Management System Award
Read more

QMS Digital Project

Project Launch | Hippocrates Supports Gaozhi Pharmaceutical in Launching Its QMS Digital Project
Read more

Project Launch

Project Launch: Hippocrates Assists Zhixing Pharmaceutical in Embarking on a New Digital Chapter of eQMS
Read more

Congratulations to Hippocrates's customer

Congratulations to Hippocrates's customer CARsgen Therapeutics on the approval and market launch of its first product, Secareza®
Read more

Congratulations to Hippocrates's customer

Congratulations to Hippocrates's customer,Gaozhi Pharmaceutical, on the approval and market launch of its Benidipine Hydrochloride Tablets!
Read more

Congratulations to Hippocrates's customer

Congratulations to Hippocrates's customer, Beide Pharmaceutical, on passing the FDA on-site audit with zero defects.
Read more

FDA Announces Plan to Gradually Phase Out Animal Testing Require

On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced a landmark policy shift: it plans to gradually phase out animal testing requirements for the development of monoclonal antibody
Read more